Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Matrix metalloproteinase-17 | ||
Ligand | BDBM50146480 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEBML_106800 | ||
IC50 | 330±n/a nM | ||
Citation | Kamei, N; Tanaka, T; Kawai, K; Miyawaki, K; Okuyama, A; Murakami, Y; Arakawa, Y; Haino, M; Harada, T; Shimano, M Reverse hydroxamate-based selective TACE inhibitors. Bioorg Med Chem Lett14:2897-900 (2004) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Matrix metalloproteinase-17 | |||
Name: | Matrix metalloproteinase-17 | ||
Synonyms: | MMP-17 | MMP17 | MMP17_HUMAN | MT-MMP 4 | MT4-MMP | MT4MMP | MTMMP4 | Matrix metalloproteinase 17 | Matrix metalloproteinase-17 | Membrane-type matrix metalloproteinase 4 | Membrane-type-4 matrix metalloproteinase | ||
Type: | PROTEIN | ||
Mol. Mass.: | 66652.56 | ||
Organism: | Homo sapiens (Human) | ||
Description: | ChEMBL_1433225 | ||
Residue: | 603 | ||
Sequence: |
| ||
BDBM50146480 | |||
n/a | |||
Name | BDBM50146480 | ||
Synonyms: | CHEMBL329967 | N-Hydroxy-N-{1-(4-hydroxyimino-cyclohexylmethyl)-2-[4-(2-methyl-quinolin-4-ylmethoxy)-benzenesulfonyl]-ethyl}-formamide | ||
Type | Small organic molecule | ||
Emp. Form. | C27H31N3O6S | ||
Mol. Mass. | 525.617 | ||
SMILES | Cc1cc(COc2ccc(cc2)S(=O)(=O)CC(CC2CCC(CC2)N=O)N(O)C=O)c2ccccc2n1 |(-1.77,-1.66,;-3.1,-.89,;-3.1,.67,;-4.43,1.42,;-4.45,2.96,;-3.12,3.73,;-1.79,2.98,;-1.79,1.44,;-.44,.68,;.89,1.46,;.87,3,;-.46,3.77,;2.22,.69,;2.99,2.03,;1.47,-.64,;3.55,-.08,;4.91,.65,;4.9,2.19,;6.21,3,;6.17,4.53,;7.47,5.34,;8.83,4.62,;8.89,3.08,;7.57,2.26,;10.13,5.44,;11.5,4.71,;6.21,-.15,;7.57,.58,;6.17,-1.69,;7.47,-2.5,;-5.76,.65,;-7.11,1.42,;-8.44,.65,;-8.44,-.89,;-7.09,-1.66,;-5.76,-.89,;-4.43,-1.66,)| | ||
Structure |